Sign in

CIK 0001598646

  • Non-accelerated filer
  • Smaller reporting company

Minerva Neurosciences, Inc.

Sign in to watch
Ticker
NERV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
260784194
Phone
+1 617-600-7373
Business address
1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 29 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +1,690,700 1,690,700
2025-12-22 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +2,250,000 2,250,000
2024-12-05 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +105,000 105,000
2023-10-04 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +100,450 100,450
2023-05-02 Luthringer Remy CEO Sale −3,641 $3.76 $14K 68,994
2023-05-01 Luthringer Remy CEO Sale −23,753 $3.85 $91K 72,635
2023-04-28 Luthringer Remy CEO Grant or award +88,077 96,388
2022-12-13 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +45,000 45,000
2022-02-16 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +505,000 505,000
2020-12-16 Luthringer Remy CEO Sale −1,300 $2.64 $3K 66,490
2020-12-14 Luthringer Remy CEO Option exercise +18,750 67,790
2020-12-14 Luthringer Remy CEO Option exercise · Restricted Stock Unit −18,750 0
2020-10-13 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +200,000 200,000
2020-06-19 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +354,302 354,302
2019-12-31 Luthringer Remy CEO Grant or award · Employee Stock Option (right to buy) +95,698 95,698
2019-12-17 Luthringer Remy CEO Sale −2,412 $7.10 $17K 49,040
2019-12-14 Luthringer Remy CEO Option exercise +18,750 51,452
2019-12-14 Luthringer Remy CEO Option exercise · Restricted Stock Unit −18,750 18,750
2018-12-17 Luthringer Remy CEO Sale −2,604 $7.46 $19K 32,702
2018-12-14 Luthringer Remy CEO Option exercise +18,750 35,306

Page 1 of 2 · 36 trades